The prevalence of dyslipidemia in patients with prostate cancer
The study demonstrated that a longer duration of androgen deprivation therapy was associated with a higher prevalence of dyslipidemia. Understanding the relationship between dyslipidemia and prostate cancer may help improve the management and treatment outcomes for patients with prostate cancer.
Authors
- Taek Won Kang (ORCID: https://orcid.org/0000-0002-7708-819X)
- Eu Chang Hwang (ORCID: https://orcid.org/0000-0002-2031-124X)
- Do Gyeong Lim (ORCID: https://orcid.org/0000-0002-5955-0758)
- Seung Il Jung (ORCID: https://orcid.org/0000-0003-4864-8175)
- Ho Seok Chung (ORCID: https://orcid.org/0000-0001-9883-1539)
- Dong Deuk Kwon
- Tae Hyung Kim (ORCID: https://orcid.org/0009-0009-4293-1499)
Institutions
- Chonnam National University Hospital (KR)
Publication Details
- Journal
- Prostate International
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1016/j.prnil.2025.03.005
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00